Ken Griffin Cytek Biosciences, Inc. Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$5.3 - $6.91 $1,060 - $1,382	200 New	200 $1,000
Q3 2023 Nov 14, 2023	SELL	$5.52 - $9.5 $109,847 - $189,050	-19,900 Reduced 76.54%	6,100 $33,000
Q2 2023 Aug 14, 2023	BUY	$6.69 - $11.99 $20,739 - $37,169	3,100 Added 13.54%	26,000 $222,000
Q1 2023 May 15, 2023	SELL	$8.44 - $13.47 $319,032 - $509,166	-37,800 Reduced 62.27%	22,900 $210,000
Q4 2022 Feb 14, 2023	SELL	$9.71 - $15.86 $81,564 - $133,224	-8,400 Reduced 12.16%	60,700 $619,000
Q3 2022 Nov 14, 2022	BUY	$10.96 - $15.45 $757,336 - $1.07 Million	69,100 New	69,100 $1.02 Million

132

74M

200

100

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $972M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.